Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.12 USD | +0.20% | -2.10% | +21.33% |
May. 31 | Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US | MT |
May. 27 | Global markets live: UBS, Tesla, Nvidia, Apple, Micron... |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.33% | 298M | |
+15.55% | 121B | |
+12.66% | 107B | |
-2.53% | 24.82B | |
+1.14% | 22.48B | |
-9.74% | 18.32B | |
-42.28% | 16.33B | |
-18.92% | 15.31B | |
+6.19% | 14.08B | |
+28.83% | 11.74B |
- Stock Market
- Equities
- VNDA Stock
- News Vanda Pharmaceuticals Inc.
- Earnings Flash (VNDA) VANDA PHARMACEUTICALS Reports Q1 Revenue $47.5M